"La OSI Bilbao-Basurto (OSI BB) de Osakidetza nació el 31 de enero de 2014 fruto de la integración de dos Organizaciones de Servicios Sanitarios previas, la Comarca Bilbao de Atención Primaria y el Hospital Universitario Basurto (HUB), y es una de las 19 Organizaciones de Servicios pertenecientes al Ente Público de Derecho Privado Osakidetza – Servicio Vasco de Salud. Nuestra Misión es atender las necesidades de salud de las personas y la promoción de su salud, de forma segura, integral, eficiente y de calidad, todo ello desde una perspectiva sanitaria pública, y estando comprometidos con la formación de profesionales excelentes, la investigación y la generación de conocimiento."

During the past decade, Hospital de Basurto conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 38 clinical trials were completed, i.e. on average, 34.2% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 23 clinical trials were completed. i.e. 39.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Basurto" #1 sponsor was "Janssen Research & Development, LLC" with 12 trials, followed by "Fundación GECP" with 8 trials sponsored, "PETHEMA Foundation" with 8 trials sponsored, "Spanish Breast Cancer Research Group" with 8 trials sponsored and "Eli Lilly and Company" with 8 trials sponsored. Other sponsors include 124 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Basurto" #1 collaborator was "Bristol-Myers Squibb" with 5 trials as a collaborator, "Abbott" with 4 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator and "Hoffmann-La Roche" with 3 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 77 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Basurto" are "Breast Cancer" (6 trials), "Amyotrophic Lateral Sclerosis" (5 trials), "Arthritis, Psoriatic" (5 trials), "HIV Infection" (5 trials) and "Arthritis, Rheumatoid" (4 trials). Many other conditions were trialed in "Hospital de Basurto" in a lesser frequency.

Most popular intervention types in "Hospital de Basurto" are "Drug" (119 trials), "Other" (22 trials), "Biological" (10 trials), "Device" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Paclitaxel" (7 trials), "Carboplatin" (5 trials), "Capecitabine" (4 trials) and "Fulvestrant" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Basurto" are 152 trials for "All" genders, 15 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Basurto". undefined are not yet recruiting, 45 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 93 completed trials in Hospital de Basurto, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Basurto, 4 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 10 trials that are defined as “Not Applicable".